Related search

P1.13-13 Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Evolution of Acquired Resistance to Anti-Cancer Therapy

Journal of Theoretical Biology
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology SimulationImmunologyBiological SciencesMedicineAgriculturalModeling
2014English

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-Egfr Therapy and Molecularly Selected by Circulating Tumor DNA Analyses

JAMA Oncology
Cancer ResearchOncology
2018English

Introduction of theCIITAgene Into Tumor Cells Produces Exosomes With Enhanced Anti-Tumor Effects

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2011English

WL-276, an Antagonist Against BCL-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth

Cancer Research
Cancer ResearchOncology
2008English

ACE2 Overexpression Inhibits Acquired Platinum Resistance-Induced Tumor Angiogenesis in NSCLC

Oncology Reports
MedicineCancer ResearchOncology
2016English

Tumor Localization of an Anti-TGF-Β Antibody and Its Effects on Gliomas

International Journal of Oncology
Cancer ResearchOncology
2010English

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

Endocrine Delivery System of NK4, an HGF-Antagonist and Anti-Angiogenic Regulator, for Inhibitions of Tumor Growth, Invasion and Metastasis

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy